Patch grafting, strategies for transplantation of organoids into solid organs such as liver
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Epithelial cell therapies have been at an impasse because of inefficient methods of transplantation to solid organs. Patch grafting strategies were established enabling transplantation of ≥107th organoids/patch of porcine GFP+ biliary tree stem/progenitors into livers of wild type hosts. Grafts consisted of organoids embedded in soft (~100 Pa) hyaluronan hydrogels, both prepared in serum-free Kubota’s Medium; placed against target sites; covered with a silk backing impregnated with more rigid hyaluronan hydrogels (~700 Pa); and use of the backing to tether grafts with sutures or glue to target sites. Hyaluronan coatings (~200–300 Pa) onto the serosal surface of the graft served to minimize adhesions with neighboring organs. The organ’s clearance of hyaluronans enabled restoration of tissue-specific paracrine and systemic signaling, resulting in return of normal hepatic histology, with donor parenchymal cells uniformly integrated amidst host cells and that had differentiated to mature hepatocytes and cholangiocytes. Grafts containing donor mature hepatocytes, partnered with endothelia, and in the same graft biomaterials as for stem/progenitor organoids, did not engraft. Engraftment occurred if porcine liver-derived mesenchymal stem cells (MSCs) were co-transplanted with donor mature cells. RNA-seq analyses revealed that engraftment correlated with expression of matrix-metalloproteinases (MMPs), especially secreted isoforms that were found expressed strongly by organoids, less so by MSCs, and minimally, if at all, by adult cells. Engraftment with patch grafting strategies occurred without evidence of emboli or ectopic cell distribution. It was successful with stem/progenitor organoids or with cells with a source(s) of secreted MMP isoforms and offers significant potential for enabling cell therapies for solid organs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hyaluronan: its nature, distribution, functions and turnover.
Fraser, J. R. E., Laurent, T. C., & Laurent, U. B. G. (1997) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1997.00170.x · Cited by 2,031 · cited 1×
“Hepatic sinusoidal endothelial cells are known to be largely responsible for the uptake and catabolism of plasma hyaluronan, which allows liver to be one of the primary organs that manage the natural biodegradation of hyaluronans [49].”
BackgroundBiochemical and Biological Attributes of Matrix Metalloproteinases
Cui, N., Hu, M., & Khalil, R. A. (2017) · Progress in Molecular Biology and Translational Science · doi:10.1016/bs.pmbts.2017.02.005 · Cited by 1,359
Schwartz, S. D., Regillo, C. D., Lam, B. L., Eliott, D., Rosenfeld, P. J., Gregori, N. Z., Hubschman, J.-P., Davis, J. L., Heilwell, G., Spirn, M., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61376-3 · Cited by 1,327
Fibrin: A versatile scaffold for tissue engineering applications
Ahmed, T. A. E., Dare, E. V., & Hincke, M. (2008) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2007.0435 · Cited by 994
Human hepatocyte transplantation: current experience and future challenges
Dhawan, A., Puppi, J., Hughes, R. D., & Mitry, R. R. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.44 · Cited by 362 · cited 1×
“The greatest hope is to be able to deliver stem cells and/or early progenitors to relevant target tissues to overcome genetic defects or aberrations from chronic diseases or infections [1].”
BackgroundCAR T cells: Continuation in a revolution of immunotherapy
Singh, A. K., & McGuirk, J. P. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30823-x · Cited by 303
Khan, A. A., Shaik, M. V., Parveen, N., Rajendraprasad, A., Aleem, M. A., Aejaz, M., Srinivas, G., Avinash, T., Tiwari, S. K., Kumaresan, K., et al. (2010) · Cell Transplantation · doi:10.3727/096368910x498241 · Cited by 183
Cited by
Jin, Y., Zhang, J., Xu, Y., Yi, K., Li, F., Zhou, H., Wang, H., Chan, H. F., Lao, Y.-H., Lv, S., et al. (2023) · Bioactive Materials · doi:10.1016/j.bioactmat.2023.05.001 · Cited by 55
Li, F., Wei, H., Jin, Y., Xue, T., Xu, Y., Wang, H., Ju, E., Tao, Y., & Li, M. (2023) · ACS Nano · doi:10.1021/acsnano.3c08495 · Cited by 23
Udagawa, D., Nagata, S., Yagi, H., Nishi, K., Morisaku, T., Adachi, S., Nakano, Y., Tanaka, M., Hori, S., Hasegawa, Y., et al. (2024) · Cell Transplantation · doi:10.1177/09636897241253700 · Cited by 11
“Many studies have demonstrated the use of orthotopic HCT coupled with biomaterials, such as cell sheets and patch grafts, as another approach to HCT 18,19 .”
BackgroundXu, Z.-Y., Wang, M., Shi, J.-Y., Liu, Y., Yu, C., Zhang, X.-Y., Zhang, C.-W., He, Q.-F., Pan, C., Zhou, J., et al. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.101700 · Cited by 5
“6A) [7,54].”
Influential
Metadata
- Authors
- Zhang, W., Lanzoni, G., Hani, H., Overi, D., Cardinale, V., Simpson, S., Pitman, W., Allen, A., Yi, X., Wang, X., Gerber, D., Prestwich, G., Lozoya, O., Gaudio, E., Alvaro, D., Tokaz, D., Dominguez-Bendala, J., Adin, C., Piedrahita, J., Mathews, K., Sethupathy, P., Carpino, G., He, Z., Wauthier, E., & Reid, L. M.
- Venue
- Biomaterials
- Publisher
- Elsevier BV
- Published
- 2021-10
- Volume
- 277
- Pages
- 121067
- ISSN
- 0142-9612 (ISSN-L)
- OpenAlex
- W3193722669
- Cited by
- 40
- References
- 7
- FWCI
- 5.72
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Patch grafting, strategies for transplantation of organoids into solid organs such as liver. https://app.cochat.ai/papers/10.1016/j.biomaterials.2021.121067
- The paper
- Zhang, W., Lanzoni, G., Hani, H., Overi, D., Cardinale, V., Simpson, S., Pitman, W., Allen, A., Yi, X., Wang, X., Gerber, D., Prestwich, G., Lozoya, O., Gaudio, E., Alvaro, D., Tokaz, D., Dominguez-Bendala, J., Adin, C., Piedrahita, J., . . . Reid, L. M. (2021). Patch grafting, strategies for transplantation of organoids into solid organs such as liver. Biomaterials. https://doi.org/10.1016/j.biomaterials.2021.121067
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.